Peptides consist of two or more amino acids connected by amide bonds in a chain form. Covalent chemical bonds are formed when the carboxyl group of one amino acid combines with the other group of amino acid. The peptide molecules are arranged in a linear or cyclic manner. Peptide antibiotics are composed of amino acids, and hence show similarity to gene-encoded polypeptides in terms of structure and mechanism of biosynthesis. Antimicrobial peptides are widely preferred for infectious disease treatment because it consists of short link of amino acid chain (12 to 100 amino acid) and can easily be isolated from single celled microorganisms.
Market Analysis and Insights: Global and United States Peptide Antibiotics Sterile Injectable Drugs Market
This report focuses on global and United States Peptide Antibiotics Sterile Injectable Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Peptide Antibiotics Sterile Injectable Drugs market size is estimated to be worth US$ million in 2025 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Ribosomal Synthesized Peptides accounting for % of the Peptide Antibiotics Sterile Injectable Drugs global market in 2025, is projected to value US$ million by 2031, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2025, and altered to an % CAGR throughout this forecast period.
In United States the Peptide Antibiotics Sterile Injectable Drugs market size is expected to grow from US$ million in 2025 to US$ million by 2031, at a CAGR of % during the forecast period.
Global Peptide Antibiotics Sterile Injectable Drugs Scope and Market Size
Peptide Antibiotics Sterile Injectable Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Peptide Antibiotics Sterile Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2025-2031.
For United States market, this report focuses on the Peptide Antibiotics Sterile Injectable Drugs market size by players, by Type and by Application, for the period 2025-2031. The key players include the global and local players, which play important roles in United States.
Segment by Type
Ribosomal Synthesized Peptides
Non-ribosomal Synthesized Peptides
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Novartis
Eli Lilly
Takeda Pharmaceutical Co. Ltd
GlaxoSmithKline
Abbott Laboratories
Sanofi
Baxter International
AstraZeneca
Merck
1 Study Coverage
1.1 Peptide Antibiotics Sterile Injectable Drugs Product Introduction
1.2 Global Peptide Antibiotics Sterile Injectable Drugs Outlook 2021 VS 2025 VS 2031
1.2.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in US$ Million for the Year 2025-2031
1.2.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume for the Year 2025-2031
1.3 United States Peptide Antibiotics Sterile Injectable Drugs Outlook 2021 VS 2025 VS 2031
1.3.1 United States Peptide Antibiotics Sterile Injectable Drugs Sales in US$ Million for the Year 2025-2031
1.3.2 United States Peptide Antibiotics Sterile Injectable Drugs Sales in Volume for the Year 2025-2031
1.4 Peptide Antibiotics Sterile Injectable Drugs Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4.1 The Market Share of United States Peptide Antibiotics Sterile Injectable Drugs in Global, 2021 VS 2025 VS 2031
1.4.2 The Growth Rate of Peptide Antibiotics Sterile Injectable Drugs Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.5 Peptide Antibiotics Sterile Injectable Drugs Market Dynamics
1.5.1 Peptide Antibiotics Sterile Injectable Drugs Industry Trends
1.5.2 Peptide Antibiotics Sterile Injectable Drugs Market Drivers
1.5.3 Peptide Antibiotics Sterile Injectable Drugs Market Challenges
1.5.4 Peptide Antibiotics Sterile Injectable Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Peptide Antibiotics Sterile Injectable Drugs Market Segment by Type
2.1.1 Ribosomal Synthesized Peptides
2.1.2 Non-ribosomal Synthesized Peptides
2.2 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Type
2.2.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value, by Type (2021, 2025 & 2031)
2.2.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume, by Type (2021, 2025 & 2031)
2.2.3 Global Peptide Antibiotics Sterile Injectable Drugs Average Selling Price (ASP) by Type (2021, 2025 & 2031)
2.3 United States Peptide Antibiotics Sterile Injectable Drugs Market Size by Type
2.3.1 United States Peptide Antibiotics Sterile Injectable Drugs Sales in Value, by Type (2021, 2025 & 2031)
2.3.2 United States Peptide Antibiotics Sterile Injectable Drugs Sales in Volume, by Type (2021, 2025 & 2031)
2.3.3 United States Peptide Antibiotics Sterile Injectable Drugs Average Selling Price (ASP) by Type (2021, 2025 & 2031)
3 Market by Application
3.1 Peptide Antibiotics Sterile Injectable Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Application
3.2.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value, by Application (2021, 2025 & 2031)
3.2.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 Global Peptide Antibiotics Sterile Injectable Drugs Average Selling Price (ASP) by Application (2021, 2025 & 2031)
3.3 United States Peptide Antibiotics Sterile Injectable Drugs Market Size by Application
3.3.1 United States Peptide Antibiotics Sterile Injectable Drugs Sales in Value, by Application (2021, 2025 & 2031)
3.3.2 United States Peptide Antibiotics Sterile Injectable Drugs Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 United States Peptide Antibiotics Sterile Injectable Drugs Average Selling Price (ASP) by Application (2021, 2025 & 2031)
4 Global Peptide Antibiotics Sterile Injectable Drugs Competitor Landscape by Company
4.1 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Company
4.1.1 Top Global Peptide Antibiotics Sterile Injectable Drugs Manufacturers Ranked by Revenue (2025)
4.1.2 Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Manufacturer (2021-2025)
4.1.3 Global Peptide Antibiotics Sterile Injectable Drugs Sales by Manufacturer (2021-2025)
4.1.4 Global Peptide Antibiotics Sterile Injectable Drugs Price by Manufacturer (2021-2025)
4.2 Global Peptide Antibiotics Sterile Injectable Drugs Concentration Ratio (CR)
4.2.1 Peptide Antibiotics Sterile Injectable Drugs Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Peptide Antibiotics Sterile Injectable Drugs in 2021
4.2.3 Global Peptide Antibiotics Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Peptide Antibiotics Sterile Injectable Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Peptide Antibiotics Sterile Injectable Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Peptide Antibiotics Sterile Injectable Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Peptide Antibiotics Sterile Injectable Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Peptide Antibiotics Sterile Injectable Drugs Market Size by Company
4.5.1 Top Peptide Antibiotics Sterile Injectable Drugs Players in United States, Ranked by Revenue (2025)
4.5.2 United States Peptide Antibiotics Sterile Injectable Drugs Revenue by Players (2023, 2024 & 2025)
4.5.3 United States Peptide Antibiotics Sterile Injectable Drugs Sales by Players (2023, 2024 & 2025)
5 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region
5.1 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Peptide Antibiotics Sterile Injectable Drugs Market Size in Volume by Region (2025-2031)
5.2.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Region: 2021-2025
5.2.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Forecast by Region (2025-2031)
5.3 Global Peptide Antibiotics Sterile Injectable Drugs Market Size in Value by Region (2025-2031)
5.3.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Region: 2021-2025
5.3.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Region: 2025-2031
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Peptide Antibiotics Sterile Injectable Drugs Market Size YoY Growth 2025-2031
6.1.2 North America Peptide Antibiotics Sterile Injectable Drugs Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Peptide Antibiotics Sterile Injectable Drugs Market Size YoY Growth 2025-2031
6.3.2 Europe Peptide Antibiotics Sterile Injectable Drugs Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Peptide Antibiotics Sterile Injectable Drugs Market Size YoY Growth 2025-2031
6.4.2 Latin America Peptide Antibiotics Sterile Injectable Drugs Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.1.4 Pfizer Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Corporation Information
7.2.2 Novartis Description and Business Overview
7.2.3 Novartis Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.2.4 Novartis Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.2.5 Novartis Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.3.4 Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Takeda Pharmaceutical Co. Ltd
7.4.1 Takeda Pharmaceutical Co. Ltd Corporation Information
7.4.2 Takeda Pharmaceutical Co. Ltd Description and Business Overview
7.4.3 Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.4.4 Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.4.5 Takeda Pharmaceutical Co. Ltd Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.5.4 GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Corporation Information
7.6.2 Abbott Laboratories Description and Business Overview
7.6.3 Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.6.4 Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.6.5 Abbott Laboratories Recent Development
7.7 Sanofi
7.7.1 Sanofi Corporation Information
7.7.2 Sanofi Description and Business Overview
7.7.3 Sanofi Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.7.4 Sanofi Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.7.5 Sanofi Recent Development
7.8 Baxter International
7.8.1 Baxter International Corporation Information
7.8.2 Baxter International Description and Business Overview
7.8.3 Baxter International Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.8.4 Baxter International Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.8.5 Baxter International Recent Development
7.9 AstraZeneca
7.9.1 AstraZeneca Corporation Information
7.9.2 AstraZeneca Description and Business Overview
7.9.3 AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.9.4 AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.9.5 AstraZeneca Recent Development
7.10 Merck
7.10.1 Merck Corporation Information
7.10.2 Merck Description and Business Overview
7.10.3 Merck Peptide Antibiotics Sterile Injectable Drugs Sales, Revenue and Gross Margin (2021-2025)
7.10.4 Merck Peptide Antibiotics Sterile Injectable Drugs Products Offered
7.10.5 Merck Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Peptide Antibiotics Sterile Injectable Drugs Industry Chain Analysis
8.2 Peptide Antibiotics Sterile Injectable Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Peptide Antibiotics Sterile Injectable Drugs Distributors
8.3 Peptide Antibiotics Sterile Injectable Drugs Production Mode & Process
8.4 Peptide Antibiotics Sterile Injectable Drugs Sales and Marketing
8.4.1 Peptide Antibiotics Sterile Injectable Drugs Sales Channels
8.4.2 Peptide Antibiotics Sterile Injectable Drugs Distributors
8.5 Peptide Antibiotics Sterile Injectable Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Peptide Antibiotics Sterile Injectable Drugs CAGR in Value, United States VS Global, 2021 VS 2025 VS 2031
Table 2. Peptide Antibiotics Sterile Injectable Drugs Market Trends
Table 3. Peptide Antibiotics Sterile Injectable Drugs Market Drivers
Table 4. Peptide Antibiotics Sterile Injectable Drugs Market Challenges
Table 5. Peptide Antibiotics Sterile Injectable Drugs Market Restraints
Table 6. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Peptide Antibiotics Sterile Injectable Drugs Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Peptide Antibiotics Sterile Injectable Drugs Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Peptide Antibiotics Sterile Injectable Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Manufacturer, (US$ Million), 2021-2025
Table 12. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Share by Manufacturer, 2021-2025
Table 13. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Manufacturer, (K Units), 2021-2025
Table 14. Global Peptide Antibiotics Sterile Injectable Drugs Sales Share by Manufacturer, 2021-2025
Table 15. Global Peptide Antibiotics Sterile Injectable Drugs Price by Manufacturer (2021-2025) & (US$/Unit)
Table 16. Global Peptide Antibiotics Sterile Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Peptide Antibiotics Sterile Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Antibiotics Sterile Injectable Drugs as of 2021)
Table 18. Top Players of Peptide Antibiotics Sterile Injectable Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Peptide Antibiotics Sterile Injectable Drugs Product Type
Table 20. Date of International Manufacturers Enter into Peptide Antibiotics Sterile Injectable Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Peptide Antibiotics Sterile Injectable Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Peptide Antibiotics Sterile Injectable Drugs Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 24. United States Peptide Antibiotics Sterile Injectable Drugs Revenue Share by Players, 2023, 2024 & 2025
Table 25. United States Peptide Antibiotics Sterile Injectable Drugs Sales by Players, (K Units), 2023, 2024 & 2025
Table 26. United States Peptide Antibiotics Sterile Injectable Drugs Sales Share by Players, 2023, 2024 & 2025
Table 27. Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 28. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Region (2021-2025) & (K Units)
Table 29. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Forecast by Region (2025-2031) & (K Units)
Table 30. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Region (2021-2025) & (US$ Million)
Table 31. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value Forecast by Region (2025-2031) & (US$ Million)
Table 32. North America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2025-2031) & (K Units)
Table 33. North America Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Country (2025-2031) & (US$ Million)
Table 34. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Region (2025-2031) & (K Units)
Table 35. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Region (2025-2031) & (US$ Million)
Table 36. Europe Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2025-2031) & (K Units)
Table 37. Europe Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Country (2025-2031) & (US$ Million)
Table 38. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2025-2031) & (K Units)
Table 39. Latin Americaa Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Country (2025-2031) & (US$ Million)
Table 40. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2025-2031) & (K Units)
Table 41. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Country (2025-2031) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 45. Pfizer Peptide Antibiotics Sterile Injectable Drugs Product
Table 46. Pfizer Recent Development
Table 47. Novartis Corporation Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 50. Novartis Product
Table 51. Novartis Recent Development
Table 52. Eli Lilly Corporation Information
Table 53. Eli Lilly Description and Business Overview
Table 54. Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 55. Eli Lilly Product
Table 56. Eli Lilly Recent Development
Table 57. Takeda Pharmaceutical Co. Ltd Corporation Information
Table 58. Takeda Pharmaceutical Co. Ltd Description and Business Overview
Table 59. Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 60. Takeda Pharmaceutical Co. Ltd Product
Table 61. Takeda Pharmaceutical Co. Ltd Recent Development
Table 62. GlaxoSmithKline Corporation Information
Table 63. GlaxoSmithKline Description and Business Overview
Table 64. GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 65. GlaxoSmithKline Product
Table 66. GlaxoSmithKline Recent Development
Table 67. Abbott Laboratories Corporation Information
Table 68. Abbott Laboratories Description and Business Overview
Table 69. Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 70. Abbott Laboratories Product
Table 71. Abbott Laboratories Recent Development
Table 72. Sanofi Corporation Information
Table 73. Sanofi Description and Business Overview
Table 74. Sanofi Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 75. Sanofi Product
Table 76. Sanofi Recent Development
Table 77. Baxter International Corporation Information
Table 78. Baxter International Description and Business Overview
Table 79. Baxter International Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 80. Baxter International Product
Table 81. Baxter International Recent Development
Table 82. AstraZeneca Corporation Information
Table 83. AstraZeneca Description and Business Overview
Table 84. AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 85. AstraZeneca Product
Table 86. AstraZeneca Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Business Overview
Table 89. Merck Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Peptide Antibiotics Sterile Injectable Drugs Customers List
Table 95. Peptide Antibiotics Sterile Injectable Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Antibiotics Sterile Injectable Drugs Product Picture
Figure 2. Global Peptide Antibiotics Sterile Injectable Drugs Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Peptide Antibiotics Sterile Injectable Drugs Market Size 2025-2031 (US$ Million)
Figure 4. Global Peptide Antibiotics Sterile Injectable Drugs Sales 2025-2031 (K Units)
Figure 5. United States Peptide Antibiotics Sterile Injectable Drugs Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 6. United States Peptide Antibiotics Sterile Injectable Drugs Market Size 2025-2031 (US$ Million)
Figure 7. United States Peptide Antibiotics Sterile Injectable Drugs Sales 2025-2031 (K Units)
Figure 8. United States Peptide Antibiotics Sterile Injectable Drugs Market Share in Global, in Value (US$ Million) 2025-2031
Figure 9. United States Peptide Antibiotics Sterile Injectable Drugs Market Share in Global, in Volume (K Units) 2025-2031
Figure 10. Peptide Antibiotics Sterile Injectable Drugs Report Years Considered
Figure 11. Product Picture of Ribosomal Synthesized Peptides
Figure 12. Product Picture of Non-ribosomal Synthesized Peptides
Figure 13. Global Peptide Antibiotics Sterile Injectable Drugs Market Share by Type in 2025 & 2031
Figure 14. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Type (2025-2031) & (US$ Million)
Figure 15. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Value by Type (2025-2031)
Figure 16. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2025-2031) & (K Units)
Figure 17. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Volume by Type (2025-2031)
Figure 18. Global Peptide Antibiotics Sterile Injectable Drugs Price by Type (2025-2031) & (US$/Unit)
Figure 19. United States Peptide Antibiotics Sterile Injectable Drugs Market Share by Type in 2025 & 2031
Figure 20. United States Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Type (2025-2031) & (US$ Million)
Figure 21. United States Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Value by Type (2025-2031)
Figure 22. United States Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2025-2031) & (K Units)
Figure 23. United States Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Volume by Type (2025-2031)
Figure 24. United States Peptide Antibiotics Sterile Injectable Drugs Price by Type (2025-2031) & (US$/Unit)
Figure 25. Product Picture of Hospital Pharmacies
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Product Picture of Online Pharmacies
Figure 28. Global Peptide Antibiotics Sterile Injectable Drugs Market Share by Application in 2025 & 2031
Figure 29. Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Application (2025-2031) & (US$ Million)
Figure 30. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Value by Application (2025-2031)
Figure 31. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2025-2031) & (K Units)
Figure 32. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Volume by Application (2025-2031)
Figure 33. Global Peptide Antibiotics Sterile Injectable Drugs Price by Application (2025-2031) & (US$/Unit)
Figure 34. United States Peptide Antibiotics Sterile Injectable Drugs Market Share by Application in 2025 & 2031
Figure 35. United States Peptide Antibiotics Sterile Injectable Drugs Sales in Value by Application (2025-2031) & (US$ Million)
Figure 36. United States Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Value by Application (2025-2031)
Figure 37. United States Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2025-2031) & (K Units)
Figure 38. United States Peptide Antibiotics Sterile Injectable Drugs Sales Market Share in Volume by Application (2025-2031)
Figure 39. United States Peptide Antibiotics Sterile Injectable Drugs Price by Application (2025-2031) & (US$/Unit)
Figure 40. North America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 41. North America Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 42. U.S. Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 43. Canada Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 44. Europe Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 45. Europe Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 46. Germany Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 47. France Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 48. U.K. Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 49. Italy Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 50. Russia Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 51. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 52. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 53. China Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 54. Japan Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 55. South Korea Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 56. India Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 57. Australia Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 58. Taiwan Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 59. Indonesia Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 60. Thailand Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 61. Malaysia Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 62. Philippines Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 63. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 64. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 65. Mexico Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 66. Brazil Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 67. Argentina Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 68. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 69. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 70. Turkey Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 71. Saudi Arabia Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 72. U.A.E Peptide Antibiotics Sterile Injectable Drugs Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 73. Peptide Antibiotics Sterile Injectable Drugs Value Chain
Figure 74. Peptide Antibiotics Sterile Injectable Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-01-25 16:03:39 
Pages: 107 
Tables: 146 
